Discussions with EU governments and reimbursement agencies are ongoing to agree on terms of an innovative ‘Day One’ access programme
News
Ergomed teams up with Automation Anywhere and DataRobot
The move is designed to accelerate the company’s intelligent automation strategy
New US nod for Roche’s Tecentriq in NSCLC
This is Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the US
Pharmacists should have greater powers to ensure meds access, says RPS
The proposals would enable pharmacists to amend the strength and formulation of the medicine dispensed or supply a generic alternative
UK’s coronavirus testing capacity has been ‘inadequate’, Committee finds
A 19-page letter to the Prime Minister details ten key lessons the UK government should learn from its experience of handling the pandemic so far
New COVID-10 guidelines for CKD and interstitial lung disease
The guidelines should help healthcare professionals decide what care to provide for people without COVID-19 infection or with confirmed or suspected infection safely while making the best use of NHS resources
ViiV HIV prevention trial stopped early on efficacy
ViiV said cabotegravir was found to be 69% more effective at preventing HIV acquisition than daily oral PrEP with emtricitabine/tenofovir disoproxil (FTC/TDF)
AZ/Daiichi Sankyo’s Enhertu picks up third breakthrough designation
The drug is being developed for metastatic non-small cell lung cancer (NSCLC) in patients whose tumours have an HER2 mutation and with disease progression on or after platinum-based therapy
Gov’t streams £84m into UK COVID-19 vaccines research
The move comes as Oxford Uni and AZ sign a global licensing deal for their vaccine candidate
Roche launches new blood gas digital solution
Staff without specific training to draw arterial blood can use Roche v-TAC for blood gas analysis
Exvastat wins 3.6m euro grant for COVID-19 trial
The firm will work with Vrije Universitat to produce a reformulated version of imatinib and test it in COVID-19 patients
A&E visits hit lowest level on record
Data show a 56.6% drop in attendances compared to a year ago
EU regulators approve Takeda’s Adcetris for sALCL
The decision brings a ‘much needed’ new treatment option to this patient community
NHS England unveils roadmap for urgent and planned services
‘There is a hard road ahead for both the NHS and the whole care system,’ says the NHS Confederation
FDA refuse to file BMS/bluebird bio’s CAR-T therapy
The FDA did not request additional clinical or non-clinical data
